Dr. Raul E. Davaro, MD

Dr. Davaro practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Davaro's NPI, 1538142161, was assigned on November 29, 2005. Dr. Davaro holds Pennsylvania license MD478859.

Dr. Davaro's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Davaro's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Davaro is also affiliated with Lehigh Valley Hospital-Hazleton. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Davaro to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davaro practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Davaro's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Davaro's licenses on file in 2 states: Pennsylvania and Massachusetts.

CMS data shows 780 Medicare services from Dr. Davaro across 4 procedure codes in 2024, for 400 Medicare patients. Medicare paid $70,828 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 400 Medicare patients who saw Dr. Davaro in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Davaro's median patient age at 65, with 48% women.

In 2024, Dr. Davaro wrote 194 Medicare Part D claims for 42 patients. 87% of them were for generic drugs. CMS names the drug for 109 of them, across 5 drugs with 11 or more claims each, at $3,216 in total drug cost. In 2023, CMS named 148 claims across 7 drugs.

Dr. Davaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Davaro as offering telehealth.

CMS Open Payments shows 12 general payments to Dr. Davaro from 6 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 63% of the total. Astellas Pharma US Inc paid the most, $70.